News
Zydus Lifesciences Ltd. plans to enter the global biologics contract development and manufacturing organization (CDMO) ...
Dataome curates, integrates and structures molecular, phenotypic and clinical data from public, private and proprietary ...
The genomic biomarkers market is experiencing rapid growth, driven by advancements in precision medicine, early disease ...
Stocks like Sun Pharmaceutical Industries, Zydus Lifesciences, Techno Electric & Engineering Company, R Systems International ...
As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...
Around 20% of these centres have expanded their footprint across three or more cities, signalling a trend towards multi-city ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Introduction The global market for wearable injectors is swiftly growing, propelled by the rising need for self-administration of biologics and ...
Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...
A HEALTH and Pharmaceutical Investment Mission is set to be hosted from today (Monday, June 2, 2025), led by the European Union (EU) Delegation in ...
In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...
StockStory.org on MSN15d
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results